Trial site
Specjalistyczny Szpital Onkologiczny NU-MED Sp. z o.o.
- 12running trials
- 5closed trials
The trials here
What the 17 trials at this site are about, from their registry records.
- Conditions
- Lung cancer6 trials
- Metastatic breast cancer4 trials
- Colorectal cancer2 trials
- Gastric and oesophageal cancer2 trials
- Melanoma1 trial
- Pancreatic cancer1 trial
- Triple-negative breast cancer1 trial
- Phase
- Phase 313 trials
- Phase 23 trials
- Phase 2/31 trial
- Status
- Active, not recruiting9 trials
- Completed5 trials
- Recruiting2 trials
- Not yet recruiting1 trial
- Lead sponsor
- AstraZeneca5 trials
- AstraZeneca AB3 trials
- Aprogen Inc.1 trial
- Astrazeneca AB1 trial
- BioNTech SE1 trial
- and 6 more
Running trials
Recruiting
A Study of Alisertib and Paclitaxel in Patients With Small Cell Lung Cancer (SCLC)
Active, not recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
A Study of SGN-B6A Versus Docetaxel in Previously Treated Non-small Cell Lung Cancer
Active, not recruiting
Study of XL092 + Atezolizumab vs Regorafenib in Participants With Metastatic Colorectal Cancer
Active, not recruiting
Active, not recruiting
Active, not recruiting
Capivasertib + CDK4/6i + Fulvestrant for Advanced/Metastatic HR+/HER2- Breast Cancer (CAPItello-292)
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Gastric and oesophageal cancer1 recruiting
- Lung cancer1 recruiting
- Pancreatic cancer1 recruiting
Closed trials
Completed
Completed
Active, not recruiting
Completed
Active, not recruiting
Site data: ClinicalTrials.govUpdated 14 Nov 2026